SHG:688488 - Jiangsu Aidea Pharmaceutical Co Ltd

Jiangsu Aidea Pharmaceutical C
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2016	2017	2018	2019	2020	2021	2022	2023	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	255.71M -11.5%	244.22M -4.5%	411.36M 68.4%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	170.84M 18.4%	139.45M -18.4%	221.34M 58.7%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	84.87M -41.4%	104.77M 23.4%	190.03M 81.4%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	302.89M 25.6%	357.3M 18.0%	479.71M 34.3%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	132.06M 36.3%	217.86M 65.0%	258.37M 18.6%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	-47.18M -	-113.08M -	-68.35M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	-29.99M -	-124.09M -	-76.07M -
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	-29.99M -	-124.09M -	-76.07M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	-0.07 -	-0.3 -	-0.18 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	-0.07 -	-0.3 -	-0.18 -